LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 575-579

Spandidos Publications

Access to resources Recommend Favorite

PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus

By              

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1581-1588

Spandidos Publications

Access to resources Recommend Favorite

Differential effects of calcium antagonists on ABCG2/BCRP-mediated drug resistance and transport in SN-38-resistant HeLa cells

By Takara Kohji   Matsubara Mika   Yamamoto Kazuhiro   Minegaki Tetsuya   Takegami Shigehiko   Takahashi Minoru   Yokoyama Teruyoshi   Okumura Katsuhiko  

Molecular Medicine Reports, Vol. 5, Iss. 3, 2012-03 ,pp. : 603-609

Spandidos Publications

Access to resources Recommend Favorite

Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells

By    

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1345-1350

Spandidos Publications

Access to resources Recommend Favorite

A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma

By Yamada Takeshi   Horinaka Mano   Shinnoh Masahide   Yoshioka Takashi   Miki Tsuneharu   Sakai Toshiyuki  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-10 ,pp. : 1080-1086

Spandidos Publications

Access to resources Recommend Favorite